NEW YORK (GenomeWeb News) – Sigma-Aldrich today reported its third-quarter sales grew 2 percent year over year on soft demand from its research end markets and a 6 percent negative effect from foreign currency exchange.

The St. Louis-based chemicals and research products firm reported total sales of $639 million for the three months ended Sept. 30 compared to $626 million in sales for the third quarter of 2011. It fell short of Wall Street's consensus estimate of $657.6 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: transcript patterns in drug-resistant cancer cells, function of high-altitude adaption gene, and more.

Monitoring gene expression changes could help sniff out athletes using performance-enhancing drugs, New Scientist says.

The University of Southern California lodges a cross-complaint in its legal dispute with the University of California, San Diego, over a large Alzheimer's disease project.

A National Science Foundation-funded project aims to give researchers access to a network many times faster than the Internet.